Friday, December 19, 2014 1:05:58 PM
it makes no sense for Hensley as Itonis Pharma to be doing what he could be doing under Migranade for emesyl where he owns the whole 9 yards. If he has more irons in the fire product wise he has 2 choices of companies in which to pursue that, but I figure with Oasis being his lab I think Migranade would be the preference, which does not help ITNS at all.
right now, Itonis (non-pharma) has only what comes under myec, which for the moment is zilch
so I feel that the situation between Cheung and Hensley is still very vague, in dealing with a product common to two companies in some way
Cheung does not "own" Hensley and whatever he does
it is way over my head
Are we rich yet?
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM